Gydantis Pharmaceuticals LLP

Gydantis Pharmaceuticals LLP - chemicals in Rohini, Delhi, India. Directors, charges & compliance details.
LLPIN AAV-3365 Incorporated 04 January 2021 ROC Delhi HQ Rohini, Delhi, India
Active Limited Liability Partnership chemicals
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
5 yrs
Est. 2021
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Delhi
ROC office
Incorporated
04 Jan 2021
Date of incorporation
Entity type
LLP
As registered with MCA

About Gydantis Pharmaceuticals LLP

Data last updated:

Gydantis Pharmaceuticals LLP is a limited liability partnership (LLP) based in Rohini, Delhi, India, recognised as a startup by DPIIT. It operates in the chemicals and chemical products segment of the chemicals sector. It was incorporated on 04 January 2021 and has been in existence for over 5 years.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAV-3365.

The LLP has a total obligation of contribution of β‚Ή1 Lakh. It is led by designated partners Anuj Kumar Handa and Neelam Singh.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Garage No 200 Block C Gh 4 Rohini Heights Apartment Sector 2, 9, Delhi, India – 110082.

Gydantis Pharmaceuticals LLP is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-04-0020114). For more details, the LLP can be reached via its website gydantis.com.

Company Details of Gydantis Pharmaceuticals LLP
LLPIN AAV-3365
Incorporation Date 04 January 2021
Total Obligation of Contribution β‚Ή1 Lakh
ROC Delhi
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification MSME
Udyam Registration UDYAM-DL-04-0020114
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Garage No 200 Block C Gh 4 Rohini Heights Apartment Sector 2, 9, Delhi, India – 110082
  • Industry
    Chemicals, Chemicals and Chemical Products, Manufacturing
Comprehensive company report
Gydantis Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout Β· GST invoice included

Unlock the full Gydantis Pharmaceuticals LLP report

Financials, compliance, directors, charges, ownership and filings for Gydantis Pharmaceuticals LLP in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Designated Partners of Gydantis Pharmaceuticals LLP

Gydantis Pharmaceuticals has 2 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Anuj Kumar HandaDesignated Partner04 Jan 20215 Years 9 MonthsCurrent
Neelam SinghDesignated Partner04 Jan 20242 Years 9 MonthsCurrent

Financials of Gydantis Pharmaceuticals LLP FY 2025 filings available

Financial Statement Summary of Gydantis Pharmaceuticals LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax••••••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Gydantis Pharmaceuticals LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin••••••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Gydantis Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Gydantis Pharmaceuticals LLP

Gydantis Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Gydantis Pharmaceuticals LLP

Employment history and EPFO contributions of people linked to Gydantis Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Gydantis Pharmaceuticals LLP

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Gydantis Pharmaceuticals LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Gydantis Pharmaceuticals LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Gydantis Pharmaceuticals LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Gydantis Pharmaceuticals LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Gydantis Pharmaceuticals LLP

Activity
31 Mar 2025
Gydantis Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Activity
31 Mar 2025
Gydantis Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Directors
04 Jan 2024
Neelam Singh was appointed as a Designated Partner on 04 Jan 2024 & has been associated with this company since 2 years 9 months.
Directors
04 Jan 2021
Anuj Kumar Handa was appointed as a Designated Partner on 04 Jan 2021 & has been associated with this company since 5 years 9 months.
Activity
04 Jan 2021
Gydantis Pharmaceuticals Llp was registered on 04 Jan 2021 with Roc Delhi I & aged 5 years 9 months as per MCA records.

Frequently Asked Questions about Gydantis Pharmaceuticals LLP

Gydantis Pharmaceuticals is an active limited liability partnership based in Rohini, Delhi, India. The LLP works in chemicals and chemical products, within the chemicals industry. It was incorporated on 04 January 2021 (5+ years old) and is registered under LLPIN AAV-3365.

Gydantis Pharmaceuticals has 2 current designated partners:

The LLPIN (Limited Liability Partnership Identification Number) of Gydantis Pharmaceuticals is AAV-3365. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Gydantis Pharmaceuticals was incorporated on 04 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.

Yes, Gydantis Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Gydantis Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-DL-04-0020114).

Gydantis Pharmaceuticals can be reached through the website gydantis.com. Its registered office is in Rohini, Delhi, India.

The registered office of Gydantis Pharmaceuticals is at Garage No 200 Block C Gh 4 Rohini Heights Apartment Sector 2, 9, Delhi, India – 110082.

The total obligation of contribution is β‚Ή1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available